🇺🇸 Epinephrine Injection in United States

722 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 722

Most-reported reactions

1. Product Quality Issue — 286 reports (39.61%)
2. Device Failure — 112 reports (15.51%)
3. Off Label Use — 74 reports (10.25%)
4. Liquid Product Physical Issue — 60 reports (8.31%)
5. Drug Ineffective — 42 reports (5.82%)
6. Drug Ineffective For Unapproved Indication — 38 reports (5.26%)
7. Product Use In Unapproved Indication — 36 reports (4.99%)
8. Drug Interaction — 26 reports (3.6%)
9. Accidental Exposure To Product — 24 reports (3.32%)
10. Product Storage Error — 24 reports (3.32%)

Source database →

Frequently asked questions

Is Epinephrine Injection approved in United States?

Epinephrine Injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Epinephrine Injection in United States?

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's is the originator. The local marketing authorisation holder may differ — check the official source linked above.